Skip to main content
STTK
NASDAQ Life Sciences

Shattuck Labs Finalizes $86.25M Public Offering at Discounted Price

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$4.165
Mkt Cap
$319.374M
52W Low
$0.712
52W High
$8.33
52W Position info
485% above low
Off High info
50% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

STTK has more than doubled off its 52-week low of $0.712 on light trading volume (0.4× avg).

Summary

Shattuck Labs finalized an $86.25 million public offering of common stock and pre-funded warrants, a highly dilutive event priced at a discount to the current market.


Key Events · Financing and Capital Events · STTK

  • Offering Finalized

    Shattuck Labs entered into an underwriting agreement to sell 13,691,876 shares of common stock (including full exercise of underwriters' option) at $4.00 per share and 7,870,624 pre-funded warrants at $3.9999 per warrant. The offering is expected to close on June 11, 2026.

  • Significant Capital Raise

    The offering is expected to generate approximately $86.25 million in gross proceeds, providing substantial capital for the company's operations.

  • High Dilution

    The capital raise represents about 27% of the company's current market capitalization, indicating significant dilution for existing shareholders.

  • Discounted Pricing

    The offering price of $4.00 per share and $3.9999 per pre-funded warrant is at a discount to the current market price of $4.165.


Analysis · STTK · Life Sciences

Shattuck Labs has finalized the terms of its public offering, raising approximately $86.25 million through the sale of common stock and pre-funded warrants. This substantial capital raise, representing about 27% of the company's market capitalization, is highly dilutive for existing shareholders and was priced at a discount to the current market price. While providing significant cash to extend the company's operational runway, the terms reflect the cost of capital for a clinical-stage biotech.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, STTK was trading at $4.17 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $319.4M. The 52-week trading range was $0.71 to $8.33. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

STTK - Latest Insights

STTK
Nov 05, 2026, 8:02 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.50
Real-time Price: $4.47 info
Change: -$1.03 (-19%) info
Market Cap: $454.218M info
STTK
Nov 05, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.50
Real-time Price: $4.47 info
Change: -$1.03 (-19%) info
Market Cap: $454.218M info
STTK
Oct 01, 2026, 7:04 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $6.79
Real-time Price: $4.47 info
Change: -$2.32 (-34%) info
Market Cap: $454.218M info
STTK
Aug 11, 2026, 6:59 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.00
Real-time Price: $4.47 info
Change: -$2.53 (-36%) info
Market Cap: $454.218M info
STTK
Aug 11, 2026, 6:57 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.00
Real-time Price: $4.47 info
Change: -$2.53 (-36%) info
Market Cap: $454.218M info